Powering the UK's approach to Antimicrobial Resistance

The threat posed by drug resistance is real, urgent and devastating. In 2019 almost five million deaths were associated with bacterial AMR, with over a million directly attributable to it. If unaddressed, AMR-related deaths could rise to a staggering 10 million by 2050. While AMR cannot be solved or reversed, it can, and must, be managed to avert this global disaster.

The UK has been a world-leader in addressing this threat, and in 2019 published a new 20-year vision and five-year national action plan. However, the need to take further, tangible action cannot be overstated, and there is a huge opportunity to build on the new approaches to infection control, diagnostics, monitoring and vaccination developed in response to Covid-19. Lessons from the pandemic can help us avert an even greater crisis.

This roundtable event will explore the tangible steps needed to make rapid progress in stemming the rise of AMR, considering who needs to do what at each level, from central government, through the health service, to communities and individuals.

Reform is delighted to host this roundtable, led by Dr Colin Brown, Director of Clinical and Emerging Infections for the UK Health Security Agency.

This event is kindly sponsored by BD and will be held under the Chatham House rule.

If you are interested in attending this event, please contact events@reform.uk